• Corpus ID: 211010888

GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker

@article{Kasanda2020GEANT4SO,
  title={GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker},
  author={Eva Kasanda and C Burbadge and Vinzenz Bildstein and J. Turko and Artemis Spyrou and Cornelia Hohr and D. Mucher},
  journal={arXiv: Medical Physics},
  year={2020}
}
In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, $^{92}$Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions between the proton beam and marker nucleus result in the emission of delayed characteristic $\gamma$ rays… 

References

SHOWING 1-10 OF 39 REFERENCES

Proton range verification through prompt gamma-ray spectroscopy

Results show that quantitative prompt gamma-ray measurements enable knowledge of nuclear reaction cross sections to be used for precise proton range verification in the presence of tissue with an unknown composition.

Compton Camera and Prompt Gamma Ray Timing: Two Methods for In Vivo Range Assessment in Proton Therapy

The first tests of the timing method at a clinical proton accelerator are summarized, its applicability in a clinical environment for challenging the current safety margins is assessed, and the factors limiting its precision are discussed.

3D prompt gamma imaging for proton beam range verification

3D PG imaging for proton range verification under clinical beam delivery conditions is possible with a single Compton camera, and shifts in the proton beam range as small as 2 mm could be detected for delivery of a 2 Gy spot.

Particle radiography and autoactivation.

Experimental study on the feasibility of in-beam PET for accurate monitoring of proton therapy

The clinical feasibility of in-beam PET for proton therapy monitoring is strongly supported and the possible extraction of valuable clinical information as particle range in-vivo, irradiation field position, and even local deviations from the dose prescription on the basis of the comparison between measured and predicted activity distributions is indicated.

Range uncertainties in proton therapy and the role of Monte Carlo simulations

  • H. Paganetti
  • Physics, Medicine
    Physics in medicine and biology
  • 2012
A significant impact of Monte Carlo dose calculation can be expected in complex geometries where local range uncertainties due to multiple Coulomb scattering will reduce the accuracy of analytical algorithms and in these cases Monte Carlo techniques might reduce the range uncertainty by several mm.

In vivo proton range verification: a review

In this review, state-of-the art in vivo proton range verification methods currently being proposed, developed or clinically implemented are described and compared.

Evaluation of the water-equivalence of plastic materials in low- and high-energy clinical proton beams.

Evaluated water-equivalence of new trial plastics designed specifically for light-ion beam dosimetry as well as commercially available plastics in clinical proton beams showed no advantage and different magnitudes of corrections were found between Geant4 and FLUKA for the various materials.

A practical solution of the Bethe equation in the energy range applicable to radiotherapy and radionuclide production

A regular perturbation method is used to solve the Bethe equation in the limit of small relativistic effects, with particular focus on incident energy level relevant to radionuclide production and radiotherapy applications, i.e. 10–200 MeV.